Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 16, 2026 09:20 ET | Source: Wohl & Fruchter LLP

NUVL Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Nuvalent to GSK

We are investigating the fairness of the proposed sale of Nuvalent to GSK for $124.00 per share in cash in a tender offer.